PerkinElmer Inc.

Sector and Industry

Healthcare, Healthcare Equipment

Performance (1Y)

16.65%

Market Cap

10.83 Bil.

P/E Ratio

46.61

Dividend Yield

0.29 %

Earnings per Share

1.84 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Abbott Laboratories185.26 Bil.39.29 Bil.33.69
-53.32 %
0.00
-
Intuitive Surgical Inc171.24 Bil.8.92 Bil.71.93
+17.90 %
0.00
-
Boston Scientific Corp120.40 Bil.17.79 Bil.49.17
+49.88 %
0.00
-
Stryker Corp.114.47 Bil.22.26 Bil.41.85
+3.99 %
0.00
-
Medtronic PLC90.93 Bil.31.27 Bil.22.35
-4.61 %
0.00
-
Siemens Healthineers AG51.40 Bil.23.38 Bil.24.04
+10.40 %
0.00
-
Hoya Corp48.59 Bil.5.43 Bil.35.69
+17.33 %
0.00
-
Becton Dickinson and Co.45.46 Bil.19.79 Bil.32.18
-3.33 %
0.00
-
Edwards Lifesciences Corp42.15 Bil.5.38 Bil.47.11
-27.44 %
0.00
-
Alcon AG33.20 Bil.9.24 Bil.38.41
-7.56 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE97.1 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 09:56:39 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW97.189.92
PREV. DAY'S PRICE93.34 (07/20)
CHANGE DAY BEFORE
+3.76
4.03 %
52 WEEK HIGH / LOW101 (06/26)69.46 (04/29)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-0.882.231.844.595.07
DIVIDENDS PER SHARE
0.260.260.250.240.24
DIVIDEND YIELD IN %
0.26 %0.25 %0.29 %--
DIVIDEND GROWTH IN %
-2.73 %-0.05 %-4.12 %--
PRICE - EARNINGS RATIO
-46.5046.6120.9818.99
PRICE - BOOK RATIO
1.711.761.50--
PRICE - SALES RATIO
4.964.993.95--
PRICE - CASH FLOW RATIO
149.4821.8919.43--
Further Key Figures

Master Data

WKN
850943
ISIN
US7140461093
SYMBOL
PKN
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Perkinelmer
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Equipment
NUMBER OF SHARES
111.56 Mil.
MARKET CAPITALISATION
10.83 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-4.17 %
8.36 %
18.51 %
-2.30 %
16.65 %
-16.88 %
-29.63 %
12.59 %
HIGH97.78101.00101.00101.00101.00122.85179.15101.00
LOW93.1085.5469.4669.4669.4669.4669.4669.46

Dividende

pro Aktie

Company profile

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.